L-Kyn mediated AhR activation promotes tumor growth with elevated levels of inflammatory cytokines (IL-6, IL-8, and IL-1β) and a decreased frequency of infiltrating cytotoxic CD8+ T cells in TME (47). The gene discussed is CD8A; the disease is neoplasm.